[DPHARMA] QoQ Quarter Result on 31-Mar-2017 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
22-May-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
31-Mar-2017 [#1]
Profit Trend
QoQ- 2.25%
YoY- 9.88%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Quarter Result
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Revenue 112,253 115,379 117,049 120,994 74,033 80,302 79,135 26.16%
PBT 12,825 14,207 12,642 11,176 6,299 7,516 7,723 40.10%
Tax -1,057 -3,080 -3,001 -2,558 2,532 -1,290 -3,782 -57.15%
NP 11,768 11,127 9,641 8,618 8,831 6,226 3,941 106.95%
-
NP to SH 11,870 11,405 9,653 8,618 8,428 6,341 4,503 90.48%
-
Tax Rate 8.24% 21.68% 23.74% 22.89% -40.20% 17.16% 48.97% -
Total Cost 100,485 104,252 107,408 112,376 65,202 74,076 75,194 21.25%
-
Net Worth 479,809 474,230 463,071 463,071 454,703 451,913 446,334 4.92%
Dividend
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Div 16,737 - 6,973 - 11,158 - 6,973 78.98%
Div Payout % 141.01% - 72.25% - 132.40% - 154.87% -
Equity
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Net Worth 479,809 474,230 463,071 463,071 454,703 451,913 446,334 4.92%
NOSH 278,959 278,959 278,959 278,959 278,959 278,959 278,959 0.00%
Ratio Analysis
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
NP Margin 10.48% 9.64% 8.24% 7.12% 11.93% 7.75% 4.98% -
ROE 2.47% 2.40% 2.08% 1.86% 1.85% 1.40% 1.01% -
Per Share
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
RPS 40.24 41.36 41.96 43.37 26.54 28.79 28.37 26.16%
EPS 4.22 3.99 3.46 3.43 3.41 2.23 1.41 107.26%
DPS 6.00 0.00 2.50 0.00 4.00 0.00 2.50 78.97%
NAPS 1.72 1.70 1.66 1.66 1.63 1.62 1.60 4.92%
Adjusted Per Share Value based on latest NOSH - 278,959
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
RPS 11.66 11.99 12.16 12.57 7.69 8.34 8.22 26.16%
EPS 1.23 1.18 1.00 0.90 0.88 0.66 0.47 89.57%
DPS 1.74 0.00 0.72 0.00 1.16 0.00 0.72 79.79%
NAPS 0.4984 0.4926 0.481 0.481 0.4723 0.4694 0.4636 4.92%
Price Multiplier on Financial Quarter End Date
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Date 29/12/17 29/09/17 30/06/17 31/03/17 30/12/16 30/09/16 30/06/16 -
Price 2.53 2.20 2.25 2.31 1.98 2.06 2.04 -
P/RPS 6.29 5.32 5.36 5.33 7.46 7.16 7.19 -8.50%
P/EPS 59.46 53.81 65.02 74.77 65.54 90.63 126.38 -39.42%
EY 1.68 1.86 1.54 1.34 1.53 1.10 0.79 65.14%
DY 2.37 0.00 1.11 0.00 2.02 0.00 1.23 54.65%
P/NAPS 1.47 1.29 1.36 1.39 1.21 1.27 1.28 9.63%
Price Multiplier on Announcement Date
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Date 28/02/18 17/11/17 25/08/17 22/05/17 24/02/17 21/11/16 22/08/16 -
Price 2.97 2.20 2.03 2.32 2.23 2.10 2.14 -
P/RPS 7.38 5.32 4.84 5.35 8.40 7.30 7.54 -1.41%
P/EPS 69.80 53.81 58.66 75.10 73.81 92.39 132.57 -34.71%
EY 1.43 1.86 1.70 1.33 1.35 1.08 0.75 53.58%
DY 2.02 0.00 1.23 0.00 1.79 0.00 1.17 43.77%
P/NAPS 1.73 1.29 1.22 1.40 1.37 1.30 1.34 18.51%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment